Viewing Study NCT01525966


Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2026-01-01 @ 1:59 PM
Study NCT ID: NCT01525966
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-03
First Post: 2012-01-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Inflammatory Breast Cancer View
None Stage IIA Breast Cancer View
None Stage IIIA Breast Cancer View
None Stage IIIB Breast Cancer View
None Stage IIIC Breast Cancer View
None Triple-negative Breast Cancer View
None Stage IIB Breast Cancer View
None Estrogen Receptor Negative View
None Progesterone Receptor Negative View
None HER2/Neu Negative View
Keywords: